St Louis, MONCT07024875Now EnrollingIRB Ready

Parkinsons Disease (PD) Clinical Trial in St Louis, MO

Access cutting-edge parkinsons disease (pd) treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.

Sponsored by Washington University School of Medicine

Quick Self-Assessment

See if you qualify for this St Louis location

Preparing your pre-screening questions…

Expert Care in St Louis

Access parkinsons disease (pd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related parkinsons disease (pd) treatment provided free

Apply for This St Louis Location

Check if you qualify for this parkinsons disease (pd) clinical trial in St Louis, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to St Louis

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit St Louis site if eligible
  4. 4Begin participation

About This Parkinsons Disease (PD) Study in St Louis

Parkinson's Disease (PD) is a neurodegenerative disorder caused by dysfunction in both subcortical structures and the cortex. The investigators recently discovered a new brain system called the Somato-Cognitive Action Network (SCAN), which could be a primary locus of dysfunction in PD. Here, the investigators will use magnetic resonance imaging techniques in PD patients to test whether SCAN is critical for PD. The investigators will determine whether SCAN is connected to PD-relevant subcortical structures, and whether PD patients exhibit altered subcortical-to-SCAN connectivity. If successful, this work will identify SCAN as a specific circuit altered in PD patients that can serve as a new target for future neuromodulatory PD therapies.

Sponsor: Washington University School of Medicine

Who Can Participate

Inclusion Criteria

Must meet specific health and cognitive criteria depending on the group. For PD participants
Clinical diagnosis of Parkinson's Disease
Must not meet dementia criteria For Healthy Control Participants
Normal or benign neurological exam
Normal cognition
No first-degree relatives with Parkinson's Disease

Exclusion Criteria

Neurological Disorders (other than PD) \- Any other neurological condition
Significant Head Injury
Head injury with loss of consciousness \>5 minutes
Or any neurological sequelae
Psychiatric Disorders
Schizophrenia
Bipolar Disorder
Serious Medical Conditions
End-stage organ failure
Ongoing cancer treatment
Cognitive Impairment
Diagnosis of dementia
MMSE score \<24 or MoCA score \<21
MRI contraindications
Metal implants
claustrophobia
Weight over 300 lbs (due to weight restrictions of the MRI scanner)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in St Louis?

Yes, this clinical trial (NCT07024875) has an active research site in St Louis, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Parkinsons Disease (PD) Treatment Options in St Louis, MO

If you're searching for parkinsons disease (pd) treatment options in St Louis, MO, this clinical trial (NCT07024875) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinsons disease (pd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all parkinsons disease (pd) clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in St Louis, MO

See all parkinsons disease clinical trials recruiting in St Louis — not just this study.

Browse Parkinsons Disease Trials in St Louis

Ready to Join in St Louis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · St Louis, MO